文献速递瓣膜外科

孤立或联合三尖瓣置换术中最佳人工瓣膜的选择

Which is the best prosthesis in an isolated or combined tricuspid valve replacement?
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

该研究比较了机械瓣与生物瓣在三尖瓣置换术中的长期结果,纳入1999年至2018年中国中部两家心脏外科中心的338例患者,分为孤立组和联合组。联合组早期死亡率高于孤立组,但机械瓣与生物瓣亚组间无显著差异。孤立组中生物瓣无事件生存率优于机械瓣,尤其对无Ebstein畸形的患者;联合组中两种瓣膜无显著差异。结论认为三尖瓣人工瓣膜选择应个体化,生物瓣可能是孤立性三尖瓣置换术患者的优选。

要点

  • 孤立性三尖瓣置换术中,生物瓣的无事件生存率优于机械瓣。
  • 无Ebstein畸形的孤立性三尖瓣置换患者,生物瓣优势同样显著。
  • 联合组中机械瓣与生物瓣的长期生存和无事件生存无显著差异。

核心结论

  • 三尖瓣人工瓣膜选择应个体化,生物瓣可能是孤立性三尖瓣置换术患者的优选,尤其对无Ebstein畸形者。

研究设计与样本

  • 患者分为孤立组和联合组(联合左心瓣膜手术),机械瓣142例(孤立组41例,联合组101例),生物瓣196例(孤立组145例,联合组51例)。

主要发现

  • 联合组早期死亡率(6例,4%)高于孤立组(3例,2%),但机械瓣与生物瓣亚组间无显著差异。
  • 孤立组中生物瓣亚组无事件生存率高于机械瓣亚组(P=0.042),无Ebstein畸形患者中同样如此(P=0.039)。
  • 联合组中机械瓣与生物瓣无事件生存率无显著差异(P=0.98)。
  • 孤立组(P=0.54)和联合组(P=0.81)中机械瓣与生物瓣的生存率相似。
  • 孤立性三尖瓣置换术中机械瓣更易发生瓣膜血栓和出血。

临床怎么用

  • 对于孤立性三尖瓣置换术患者,尤其无Ebstein畸形者,可优先考虑生物瓣以减少瓣膜相关事件。
  • 联合左心瓣膜手术的三尖瓣置换,机械瓣与生物瓣长期结果相似,选择应个体化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The debate concerning the optimal choice of tricuspid position continues. We compared the long-term results of mechanical and biological prostheses in patients who underwent isolated or combined tricuspid valve replacement, at 2 major cardiac surgical centres in central China. METHODS: From January 1999 to December 2018, 338 patients underwent tricuspid valve replacement. Patients were divided into an isolated group or a combined group according to whether their surgery was combined with a left heart valve surgery. Mechanical tricuspid valve replacement was performed in 142 patients (isolated group: 41 vs combined group: 101), and 196 patients underwent bioprosthetic tricuspid valve replacement (isolated group: 145 vs combined group: 51). Operative results, long-term survival and tricuspid valve-related events were compared. RESULTS: Early mortality in the combined group was higher (n = 6, 4%) than that in the isolated group (n = 3, 2%), but no significant difference was observed between the mechanical and biological subgroups. In the isolated group, there was a higher event-free rate in the biological subgroup than in the mechanical subgroup (P = 0.042) and a similar result was also observed for patients without Ebstein's anomaly (P = 0.039). In the combined group, no significant difference was observed (P = 0.98). Survival rates were similar between the mechanical and biological subgroups in both the isolated (P = 0.54) and combined (P = 0.81) groups. Mechanical valves in isolated tricuspid valve replacement were more prone to valve thrombosis and bleeding. CONCLUSIONS: Every decision regarding tricuspid valve prostheses should be individualized, but biological prostheses may be an optimal choice for patients, especially for patients without Ebstein's anomaly, in isolated tricuspid valve replacement.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Liu P, Xia DS, Qiao WH, et al. Which is the best prosthesis in an isolated or combined tricuspid valve replacement? Eur J Cardiothorac Surg. 2021. PMID: 33049775. doi:10.1093/ejcts/ezaa273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。